DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Valbenazine and Deutetrabenazine for Tardive Dyskinesia

By Katie T. B. Touma, PharmD, BCPP, BCPS, and Jonathan R. Scarff, MD Dr. Touma is with the William Jennings Bryan Dorn VA Medical Center Community-based Outpatient Clinic in Anderson,

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

By Ann Mcnary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: Ms. McNary

Letter to the Editor: Kratom and the Opioid Crisis

Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Bestha is with the Carolinas Healthcare System in Charlotte, North Carolina. Funding/financial disclosures. The author has no conflicts of interest relevant to the content of

Editorial Message and Issue Highlights–Vol. 15, No. 3–4, March-April 2018

Dear Colleagues: Welcome to the March–April 2018 issue of Innovations in Clinical Neuroscience (ICNS). We are excited to lead this edition of ICNS with an exciting commentary by Dr. Michael